Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).

Journal of global antimicrobial resistance - 1 Dec 2022

Seifert Harald, Blondeau Joseph, Lucaßen Kai, Utt Eric A

Abstract excerpt

OBJECTIVES: This study presents 2016-2018 in vitro antimicrobial activity data and rates of resistant phenotypes for clinical isolates of Acinetobacter baumannii from Africa/Middle East, Asia/South Pacific, Europe, Latin America, and North America. METHODS: A total of 4320 A. baumannii isolates were collected across all regions between 2016 and 2018. The in vitro antimicrobial activities of amikacin, colistin,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Amikacin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Anti-Bacterial Agents

Share to Colistin

Share to Gram-Negative Bacteria

Share to Levofloxacin

Share to Meropenem

Share to Tigecycline

Source

Identifiers

PMID: 35948242
DOI: 10.1016/j.jgar.2022.08.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).PMID 35948242Read ↗

Acinetobacter baumannii: an evolving and cunning opponentSemantic proximity Read ↗

Prevalence of Genes Involved in Colistin Resistance in Acinetobacter baumannii: First Report from Iraq.Semantic proximity Read ↗

Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Semantic proximity Read ↗

Acinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates.Semantic proximity Read ↗

Acinetobacter baumannii Antibiotic Resistance MechanismsSemantic proximity Read ↗

Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?Semantic proximity Read ↗

Prevalence of Acinetobacter baumannii Multidrug Resistance in University Hospital EnvironmentSemantic proximity Read ↗

Acinetobacter baumannii: A comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategiesSemantic proximity Read ↗

Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.Semantic proximity Read ↗

Molecular epidemiology of carbapenem and colistin resistant Acinetobacter baumaniiSemantic proximity Read ↗

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumanniiSemantic proximity Read ↗

Antibiotic Resistance Patterns and Distribution of Ampc β-Lactamases Genes Among Acinetobacter Baumannii Clinical Isolates from Hospitals of Tehran, IranSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.